Trial Details

COMPLETED
Basic Information
Clinical ID c835
Identifier NCT02426372
Trial Title Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions BIOLOGICAL: QBECO SSI
Participant Information
Sponsor Qu Biologics Inc.
City Edmonton
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-07-15
Primary Completion Date 2025-12-16
Completion Date 2025-12-16